Benaim Ely 4
4 · NovoCure Ltd · Filed May 28, 2021
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Benaim Ely
Chief Medical Officer
Transactions
- Exercise/Conversion
Options to Buy Ordinary Shares
2021-05-27−1,833→ 7,332 totalExercise: $47.56Exp: 2029-05-07→ Ordinary Shares (1,833 underlying) - Exercise/Conversion
Ordinary Shares
2021-05-27$47.56/sh+1,833$87,177→ 30,887 total - Sale
Ordinary Shares
2021-05-27$200.00/sh−1,833$366,600→ 29,054 total
Footnotes (2)
- [F1]Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim.
- [F2]Fully vested as of the date hereof.